Cargando…
A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics
Rapid innovation in (epi)genetics and biomarker sciences is driving a new drug development and product development pathway, with the personalized medicine era dominated by biologic therapeutics and companion diagnostics. Companion diagnostics (CDx) are tests and assays that detect biomarkers and spe...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730156/ https://www.ncbi.nlm.nih.gov/pubmed/26858745 http://dx.doi.org/10.3389/fgene.2015.00357 |